TELA Bio, Inc.
General ticker "TELA" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $54.4M (TTM average)
TELA Bio, Inc. does not follow the US Stock Market performance with the rate: -2.4%.
Estimated limits based on current volatility of 6.3%: low 1.00$, high 1.13$
Factors to consider:
- Total employees count: 218 (+4.3%) as of 2025
- Countries other than US accounted for 14.9% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Operating losses, Capital shortage, Regulatory and compliance, Market acceptance, Supply chain disruptions
- Earnings for 6 months up through Q2 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [0.82$, 2.37$]
- 2026-12-31 to 2027-12-31 estimated range: [0.95$, 2.60$]
Financial Metrics affecting the TELA estimates:
- Positive: with PPE of -1.4 at the end of fiscal year the price was low
- Negative: negative Operating income
- Positive: 7.04 < Shareholder equity ratio, % of 7.75 <= 12.78
- Positive: Inventory ratio change, % of -3.50 <= -1.30
- Positive: Industry inventory ratio change (median), % of 0.70 <= 1.15
- Positive: -0.14 < Investing cash flow per share per price, % of 1.58
- Positive: Interest expense per share per price, % of 9.82 <= 10.35
Short-term TELA quotes
Long-term TELA plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $58.45MM | $69.30MM | $80.28MM |
| Operating Expenses | $102.53MM | $103.42MM | $114.03MM |
| Operating Income | $-44.08MM | $-34.12MM | $-33.76MM |
| Non-Operating Income | $-2.59MM | $-3.87MM | $-4.85MM |
| Interest Expense | $5.22MM | $5.29MM | $5.25MM |
| R&D Expense | $9.62MM | $8.81MM | $9.22MM |
| Income(Loss) | $-46.66MM | $-37.98MM | $-38.60MM |
| Taxes | $0.00MM | $-0.14MM | $0.23MM |
| Net Income(Loss)* | $-46.66MM | $-37.84MM | $-38.83MM |
| Stockholders Equity | $18.88MM | $28.46MM | $6.31MM |
| Inventory | $13.16MM | $12.78MM | $11.02MM |
| Assets | $78.05MM | $86.57MM | $81.42MM |
| Operating Cash Flow | $-40.86MM | $-41.59MM | $-28.22MM |
| Capital expenditure | $0.61MM | $0.99MM | $0.45MM |
| Investing Cash Flow | $-0.60MM | $4.45MM | $0.85MM |
| Financing Cash Flow | $46.27MM | $43.06MM | $25.75MM |
| Earnings Per Share** | $-2.04 | $-1.33 | $-0.83 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.